These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


367 related items for PubMed ID: 12764110

  • 1. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury.
    Li S, Strittmatter SM.
    J Neurosci; 2003 May 15; 23(10):4219-27. PubMed ID: 12764110
    [Abstract] [Full Text] [Related]

  • 2. Nogo-66 receptor antagonist peptide promotes axonal regeneration.
    GrandPré T, Li S, Strittmatter SM.
    Nature; 2002 May 30; 417(6888):547-51. PubMed ID: 12037567
    [Abstract] [Full Text] [Related]

  • 3. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE, Liu BP, Park JH, Strittmatter SM.
    Neuron; 2004 Oct 28; 44(3):439-51. PubMed ID: 15504325
    [Abstract] [Full Text] [Related]

  • 4. Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat.
    Cao Y, Shumsky JS, Sabol MA, Kushner RA, Strittmatter S, Hamers FP, Lee DH, Rabacchi SA, Murray M.
    Neurorehabil Neural Repair; 2008 Oct 28; 22(3):262-78. PubMed ID: 18056009
    [Abstract] [Full Text] [Related]

  • 5. A re-assessment of the effects of a Nogo-66 receptor antagonist on regenerative growth of axons and locomotor recovery after spinal cord injury in mice.
    Steward O, Sharp K, Yee KM, Hofstadter M.
    Exp Neurol; 2008 Feb 28; 209(2):446-68. PubMed ID: 18234196
    [Abstract] [Full Text] [Related]

  • 6. Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury.
    Li S, Liu BP, Budel S, Li M, Ji B, Walus L, Li W, Jirik A, Rabacchi S, Choi E, Worley D, Sah DW, Pepinsky B, Lee D, Relton J, Strittmatter SM.
    J Neurosci; 2004 Nov 17; 24(46):10511-20. PubMed ID: 15548666
    [Abstract] [Full Text] [Related]

  • 7. Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury.
    Ji B, Li M, Budel S, Pepinsky RB, Walus L, Engber TM, Strittmatter SM, Relton JK.
    Eur J Neurosci; 2005 Aug 17; 22(3):587-94. PubMed ID: 16101740
    [Abstract] [Full Text] [Related]

  • 8. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D, Coffin RS, Anderson PN.
    J Neurocytol; 2002 Feb 17; 31(2):93-120. PubMed ID: 12815233
    [Abstract] [Full Text] [Related]

  • 9. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G, Tang WY.
    Int J Mol Med; 2017 Feb 17; 39(2):437-445. PubMed ID: 28075461
    [Abstract] [Full Text] [Related]

  • 10. Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment.
    Brösamle C, Huber AB, Fiedler M, Skerra A, Schwab ME.
    J Neurosci; 2000 Nov 01; 20(21):8061-8. PubMed ID: 11050127
    [Abstract] [Full Text] [Related]

  • 11. Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling.
    Mingorance A, Solé M, Munetón V, Martínez A, Nieto-Sampedro M, Soriano E, del Río JA.
    FASEB J; 2006 Mar 01; 20(3):491-3. PubMed ID: 16407455
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P, Huang L, Zou J, Yu Z, Wang Y, Wang X, Xu L, Liu X, Xu XM, Lu PH.
    Neurobiol Dis; 2008 Dec 01; 32(3):535-42. PubMed ID: 18930141
    [Abstract] [Full Text] [Related]

  • 14. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
    Gonzenbach RR, Zoerner B, Schnell L, Weinmann O, Mir AK, Schwab ME.
    J Neurotrauma; 2012 Feb 10; 29(3):567-78. PubMed ID: 21815784
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Why do Nogo/Nogo-66 receptor gene knockouts result in inferior regeneration compared to treatment with neutralizing agents?
    Teng FY, Tang BL.
    J Neurochem; 2005 Aug 10; 94(4):865-74. PubMed ID: 16092935
    [Abstract] [Full Text] [Related]

  • 20. Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice.
    Lee JK, Geoffroy CG, Chan AF, Tolentino KE, Crawford MJ, Leal MA, Kang B, Zheng B.
    Neuron; 2010 Jun 10; 66(5):663-70. PubMed ID: 20547125
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.